BridgeMD
Intra-articular corticosteroid injection vs arthrocentesis in the management of clinical arthritis of the temporomandibular joint: a randomized controlled trial.
EU CTIS ID: 2023-509114-11-00
What this study is testing
To compare pain relief of TMJ intra-articular cortisone injection versus arthrocentesis for the management of clinical TMJ arthritis
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- age ≥ 18 years
- TMJ clinical arthritis in one or both joints
- Understand swedish orally and in writing
- Given written consent to participate in the study
- Has been given information about the condition and treatment in postural exercises
You likely can't join if
- Allergy to methyl-prednisolone or any other content in the drug
- Fungusinfection that affect the body
- Local virus- or/and bacteriainfection
- TMJ joint surgery or trauma during the last two years
- Cortisone injection in the TMJ the last 3 months
- Patients whose condition can be related to other diseases for instance auto-immune disease, neurologic disease, myalgia or tooth ache
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.